BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15755855)

  • 21. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism.
    Bay K; Virtanen HE; Hartung S; Ivell R; Main KM; Skakkebaek NE; Andersson AM; ; Toppari J
    J Clin Endocrinol Metab; 2007 Oct; 92(10):4020-7. PubMed ID: 17666478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome.
    Lottrup G; Nielsen JE; Maroun LL; Møller LM; Yassin M; Leffers H; Skakkebæk NE; Rajpert-De Meyts E
    Hum Reprod; 2014 Aug; 29(8):1637-50. PubMed ID: 24908673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis.
    Safarinejad MR
    J Neuroendocrinol; 2008 Dec; 20(12):1368-75. PubMed ID: 19094084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
    McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
    J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression.
    Albrethsen J; Østergren PB; Norup PB; Sønksen J; Fode M; Kistorp C; Nordsborg NB; Solheim SA; Mørkeberg J; Main KM; Juul A
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2834-2839. PubMed ID: 37235781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
    Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
    J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testicular function in men treated in childhood for undescended testes.
    Vinardi S; Magro P; Manenti M; Lala R; Costantino S; Cortese MG; Canavese F
    J Pediatr Surg; 2001 Feb; 36(2):385-8. PubMed ID: 11172441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired testicular function in patients with carcinoma-in-situ of the testis.
    Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE
    J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.
    McLachlan RI; Finkel DM; Bremner WJ; Snyder PJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1414-9. PubMed ID: 2110576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of testosterone and insulin-like peptide 3 secretions in response to human chorionic gonadotropin in cultured interstitial cells from scrotal and retained testes in dogs.
    Pathirana IN; Ashida Y; Kawate N; Tanaka K; Tsuji M; Takahashi M; Hatoya S; Inaba T; Tamada H
    Anim Reprod Sci; 2011 Mar; 124(1-2):138-44. PubMed ID: 21377298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma insulin-like peptide 3 concentrations are acutely regulated by luteinizing hormone in pubertal Japanese Black beef bulls.
    Hannan MA; Fukami Y; Kawate N; Sakase M; Fukushima M; Pathirana IN; Büllesbach EE; Inaba T; Tamada H
    Theriogenology; 2015 Dec; 84(9):1530-5. PubMed ID: 26318230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels.
    Cabrol S; Ross JL; Fennoy I; Bouvattier C; Roger M; Lahlou N
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E746-53. PubMed ID: 21307139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like factor 3 as a marker of testicular function in obese men.
    Foresta C; Di Mambro A; Pagano C; Garolla A; Vettor R; Ferlin A
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):722-6. PubMed ID: 19226271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men.
    Neaves WB; Johnson L; Porter JC; Parker CR; Petty CS
    J Clin Endocrinol Metab; 1984 Oct; 59(4):756-63. PubMed ID: 6434579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH.
    Gromoll J; Eiholzer U; Nieschlag E; Simoni M
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2281-6. PubMed ID: 10852464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.